SMS Pharmaceuticals Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn

SMS Pharmaceuticals Ltd: Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 5.6% to ₹207 crore against Jun 2025. Net profit rose 16.7% to ₹21 crore against the same period a year earlier. Operating margin rose from 19.9% to 20.3% (0.4 percentage points higher). In the year ending Mar 2026, operations generated ₹61 crore but reported free cash flow remained negative at −₹64 crore. Check the cash-flow statement and the source definition of free cash flow.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 9 October 2026, 9:35 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price445₹ per share
Reported P/E46.0Times
Book value per share85.9₹ per share
Reported ROCE12.9 %Reported return

Stored market and accounting figures

Price record: 9 October 2026, 9:35 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap4,163 Cr.
Current Price445
High / Low494/269
Stock P/E46.0
Book Value85.9
Dividend Yield0.09 %
ROCE12.9 %
ROE11.9 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 5.6% to ₹207 crore against Jun 2025. Net profit rose 16.7% to ₹21 crore against the same period a year earlier. Operating margin rose from 19.9% to 20.3% (0.4 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 135167161246164197173248196242210238207
Expenses 109139133212131165140207157194167198165
Operating Profit 27282933333233413948444042
OPM % 20%17%18%14%20%16%19%17%20%20%21%17%20%
Other Income 1112112111432
Interest 6666554566656
Depreciation 888889991010101010
Profit before tax 13151622222023292434312728
Tax % 29%21%26%26%25%28%24%29%24%26%25%23%25%
Net Profit 9121216161417211825232121
EPS in Rs 1.101.421.441.881.931.682.032.332.052.682.492.232.26

Last Updated: September 29, 2026, 5:36 pm

EARNINGS

Annual performance

Mar 2026

Earnings grew faster than sales in the year ending Mar 2026. Sales rose 13.3% to ₹887 crore against Mar 2025. Net profit rose 29.4% to ₹88 crore against the same period a year earlier. Operating margin rose from 17.9% to 19.3% (1.4 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 4:31 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 587611438463465412563520522709783887898
Expenses 500522363369375332442405467592643716724
Operating Profit 86897593908012111555117140171174
OPM % 15%15%17%20%19%19%22%22%10%16%18%19%19%
Other Income 16412353554689
Interest 18171615121211192224192323
Depreciation 17191920192222323232344040
Profit before tax 675642606251916966693116121
Tax % 48%26%14%33%34%36%33%1%26%25%27%25%
Net Profit 3542364041336168449688891
EPS in Rs 4.154.924.204.784.893.867.208.030.485.837.719.359.66
Dividend Payout % 5%4%5%5%5%6%4%4%62%7%5%4%
Year-on-year profit growth table

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)20.00%-14.29%11.11%2.50%-19.51%84.85%11.48%-94.12%1125.00%38.78%29.41%
Change in YoY Net Profit Growth (%)0.00%-34.29%25.40%-8.61%-22.01%104.36%-73.37%-105.59%1219.12%-1086.22%-9.36%

Growth

Compounded Sales Growth
10 Years:3%
5 Years:14%
3 Years:15%
TTM:10%
Compounded Profit Growth
10 Years:7%
5 Years:16%
3 Years:0%
TTM:24%
Stock Price CAGR
10 Years:17%
5 Years:22%
3 Years:39%
1 Year:-31%
Return on Equity
10 Years:11%
5 Years:10%
3 Years:7%
Last Year:11%

Last Updated: September 5, 2025, 1:31 pm

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹365 crore in Mar 2026. They increased from ₹311 crore in Mar 2025 (17.4% higher). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: July 21, 2026, 3:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 888888888899
Reserves 246286254293331359420485487562664795
Borrowings 167204149146144157255263254281311365
Other Liabilities 119158897293103147126165217202211
Total Liabilities 5406565015195776278308839141,0681,1861,381
Fixed Assets 277370290279281280457438412437533534
CWIP 2913881842711333035116
Investments 132137454545454545454552
Other Assets 221252166187232259321389424556573679
Total Assets 5406565015195776278308839141,0681,1861,381
CASH & FUNDING

Cash generation

Mar 2026

Operating activities generated ₹61 crore in Mar 2026. Reported free cash flow for the same period was −₹64 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business. Operating cash flow was equivalent to 69.3% of the ₹88 crore reported annual profit for the same year ending Mar 2026, before capital expenditure.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 596173325040904522508261
Cash from Investing Activity + -55-79-39-17-35-43-152-27-30-52-123-132
Cash from Financing Activity + -1027-33-15-13-292-12-32314776
Net Cash Flow -69102-5316-392954
Free Cash Flow 11-27502315-3-6118-7-2-42-64
CFO/OP 75%93%110%46%70%65%88%52%49%56%73%50%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow11.00-27.0050.0023.0015.00-3.00-61.0018.00-7.00-2.00-42.00-64.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 88 in Mar 2025. That is 3 days higher than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 39373618192043683410412295
Inventory Days 9081106114135170191148333243201238
Days Payable 59587982495966709711713095
Cash Conversion Cycle 70616350105131169146270230192238
Working Capital Days 91919-227395748941048588
ROCE %12%21%16%13%18%16%13%17%12%4%11%12%
SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 68.07% in Jun 2026. Their share was 1.80 percentage points higher than in Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. FIIs held 0.65% in Jun 2026, 0.62 percentage points above their holding in Jun 2025. DIIs held 2.83% in Jun 2026, 0.20 percentage points below their holding in Jun 2025.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 64.32%64.32%64.67%64.67%64.67%64.67%66.27%66.27%68.07%68.07%68.07%68.07%
FIIs 0.60%0.59%0.17%0.18%0.52%0.31%0.08%0.03%0.28%0.04%0.31%0.65%
DIIs 0.00%0.00%1.98%2.13%2.55%2.55%2.43%3.03%2.88%3.21%3.02%2.83%
Public 35.07%35.10%33.18%33.03%32.27%32.47%31.23%30.68%28.77%28.69%28.60%28.45%
No. of Shareholders 25,24625,34130,14031,78033,13634,97335,33233,65234,15734,37832,39731,489
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund 1,859,681 0.25 75.08N/AN/AN/A
ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Distributions & retention

%

Distributions & retention

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 8.165.89-0.837.357.39
Diluted EPS (Rs.) 8.165.89-0.837.357.39
Cash EPS (Rs.) 11.489.544.2511.829.83
Book Value[Excl.RevalReserv]/Share (Rs.) 72.1563.3654.4055.5648.50
Book Value[Incl.RevalReserv]/Share (Rs.) 72.1563.3654.4055.5648.50
Revenue From Operations / Share (Rs.) 88.2983.7961.6761.4166.53
PBDIT / Share (Rs.) 16.3814.307.0214.1214.71
PBIT / Share (Rs.) 12.5110.583.2210.3212.08
PBT / Share (Rs.) 10.427.810.638.0910.76
Net Profit / Share (Rs.) 7.605.810.458.027.20
NP After MI And SOA / Share (Rs.) 7.805.89-0.837.357.39
PBDIT Margin (%) 18.5517.0711.3722.9922.11
PBIT Margin (%) 14.1612.625.2216.8018.16
PBT Margin (%) 11.799.321.0213.1716.17
Net Profit Margin (%) 8.616.930.7413.0510.82
NP After MI And SOA Margin (%) 8.837.02-1.3511.9611.10
Return on Networth / Equity (%) 10.809.29-1.5313.2315.23
Return on Capital Employeed (%) 13.3812.754.3613.1716.54
Return On Assets (%) 5.994.81-0.807.237.69
Long Term Debt / Equity (X) 0.210.220.260.310.36
Total Debt / Equity (X) 0.480.520.540.550.53
Asset Turnover Ratio (%) 0.710.740.600.610.78
Current Ratio (X) 1.721.621.611.921.59
Quick Ratio (X) 0.840.910.730.640.88
Inventory Turnover Ratio (X) 3.021.861.261.992.35
Dividend Payout Ratio (NP) (%) 4.895.09-35.974.080.00
Dividend Payout Ratio (CP) (%) 3.273.1210.132.690.00
Earning Retention Ratio (%) 95.1194.91135.9795.920.00
Cash Earning Retention Ratio (%) 96.7396.8889.8797.310.00
Interest Coverage Ratio (X) 7.835.162.716.3311.16
Interest Coverage Ratio (Post Tax) (X) 4.643.101.184.606.46
Enterprise Value (Cr.) 2151.851748.52734.331007.491231.25
EV / Net Operating Revenue (X) 2.752.471.411.942.19
EV / EBITDA (X) 14.8214.4412.368.439.88
MarketCap / Net Operating Revenue (X) 2.412.130.931.531.87
Retention Ratios (%) 95.1094.90135.9795.910.00
Price / BV (X) 2.952.811.061.692.57
Price / Net Operating Revenue (X) 2.412.130.931.531.87
EarningsYield 0.030.03-0.010.070.05

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
SMS Pharmaceuticals Ltd 4,163 Cr. 445 494/26946.0 85.90.09 %12.9 %11.9 % 1.00
Gufic BioSciences Ltd 4,080 Cr. 406 468/26855.5 66.20.02 %12.2 %9.98 % 1.00
RPG Life Sciences Ltd 4,502 Cr. 2,719 3,130/1,73138.6 3660.88 %25.7 %19.3 % 8.00
Aarti Drugs Limited 3,763 Cr. 413 534/31921.8 1540.48 %11.7 %12.7 % 10.0
Unichem Laboratories Ltd 3,752 Cr. 531 687/27830.7 3860.00 %4.13 %3.17 % 2.00
Industry Average17,127.26 Cr1,216.6253.25211.240.40%26.16%16.59%6.06

All Competitor Stocks of SMS Pharmaceuticals Ltd